Right Bundle Branch Block: Causes and Clinical Concerns
Right bundle branch block (RBBB) results from delayed or blocked conduction in the right bundle branch of the His-Purkinje system and, while often benign in isolation, serves as an important marker for underlying cardiovascular disease and carries significant prognostic implications, particularly in acute coronary syndrome and cardiogenic shock.
Etiology and Pathophysiology
RBBB develops from disruption of the right bundle branch conduction pathway. The underlying mechanisms are diverse 1:
- Developmental or congenital abnormalities
- Hereditary/genetic conditions (including Brugada syndrome, which must be differentiated)
- Ischemic injury (particularly proximal LAD occlusion affecting septal perforators)
- Inflammatory or infiltrative processes
- Degenerative fibrotic changes
- Traumatic injury (including iatrogenic from lead extraction 2)
- Metabolic derangements
- Malignant processes
The pathophysiology can be characterized as either static or progressive, which has important implications for monitoring 1.
Clinical Concerns and Risk Stratification
Acute Presentation Context
In patients presenting with chest pain and new RBBB, treat this as a STEMI equivalent requiring urgent reperfusion 3. New-onset RBBB in acute coronary syndrome indicates:
- Proximal LAD occlusion with septal perforator ischemia
- Larger infarct size
- Higher rates of cardiogenic shock
- Increased ventricular arrhythmias
- Significantly elevated mortality 3
ECG red flags for occlusion MI in RBBB include:
- Concordant ST elevation
- Excessive discordant ST elevation (>25% of QRS amplitude)
- Reciprocal changes
- New bifascicular block 3
Chronic RBBB Concerns
Population-based data reveals RBBB is not benign even in asymptomatic individuals 4:
- Mortality risk: Age-adjusted HR 1.31 for all-cause mortality and HR 1.87 for cardiovascular mortality
- MI risk: HR 1.67 for future myocardial infarction
- Pacemaker need: HR 2.17 for eventual pacemaker insertion
- No increased risk for heart failure, atrial fibrillation, or COPD in isolation 4
High-Risk Clinical Scenarios
RBBB carries particularly poor prognosis in specific contexts:
Cardiogenic shock: RBBB shows 72.5% 30-day mortality vs 50% without BBB (HR 1.807 after adjustment) 5
Cardiac arrest: In CS patients with cardiac arrest, RBBB mortality reaches 90% vs 62.2% without BBB 5
Acute coronary syndrome: Higher unadjusted in-hospital mortality (8.8% vs 3.8%) and independent predictor after risk adjustment (OR 1.45) 6
Pulmonary embolism: RBBB with QR pattern in V1 has high positive predictive value for high-risk PE causing cardiac arrest 7
Evaluation Algorithm
For newly detected RBBB, follow this structured approach:
Immediate Assessment
- Determine acuity: New vs chronic, symptomatic vs asymptomatic
- Assess for ACS: If chest pain or ischemic symptoms present, activate STEMI protocol regardless of ST changes 3
- Check for PE: If dyspnea/hypoxia with RBBB and QR pattern in V1, consider high-risk PE 7
Diagnostic Workup
Mandatory testing 1:
- Transthoracic echocardiogram to exclude structural heart disease (Class I recommendation for LBBB; Class IIa for other intraventricular conduction disorders including RBBB when structural disease suspected)
- Serial troponins if any concern for ischemia
- Ambulatory ECG monitoring if symptoms suggest intermittent bradycardia
Risk factor assessment 4:
- Male gender (2-3× more common than women)
- Increasing age
- Elevated systolic blood pressure
- Presence of incomplete RBBB (predictor of progression)
Differential Diagnosis Pitfalls
Critical distinction from Brugada syndrome 8: Look for personal or family history of sudden death. Brugada shows similar RBBB pattern but with distinct ST elevation in V1-V2.
Masquerading RBBB 9: When combined with severe left anterior fascicular block and LV enlargement, terminal forces may reorient leftward, mimicking LBBB. This variant carries particularly poor prognosis as it implies severe underlying heart disease.
Management Implications
Treatment decisions based on RBBB context:
- Acute MI with new RBBB: Urgent cardiac catheterization and revascularization 3
- Symptomatic bradycardia: Ambulatory monitoring to assess for intermittent high-grade block 1
- Asymptomatic chronic RBBB: Recognize as cardiovascular risk marker requiring aggressive risk factor modification 4
- Bifascicular block: Lower threshold for pacemaker consideration given progression risk 1
Device considerations:
- RBBB complicates subcutaneous ICD sensing (risk of T-wave oversensing and inappropriate shocks) 2
- Consider conduction system pacing (His bundle) over RV pacing when pacemaker indicated 1
Prognostic Counseling
Incomplete RBBB (IRBBB) is distinctly different 4: Unlike complete RBBB, IRBBB shows no association with adverse outcomes and should not trigger the same level of concern, though it predicts progression to complete RBBB.
Isolated RBBB rarely causes symptoms directly 1, but serves as a marker for underlying disease. The prognosis depends entirely on the associated cardiac pathology rather than the conduction abnormality itself.